Y-maBs Therapeutics Class Action Lawsuit Announced: Johnson Fistel Encourages Shareholders Submit Their Information Below Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB). The class action is on behalf of shareholders who purchased Y-mAbs Therapeutics between October 6, 2020 … Continue reading Y-mAbs Therapeutics, Inc.